Eli Lilly has launched Mounjaro, a first-of-its-kind drug for obesity and type 2 diabetes, in India. This medication, ...

FORGET a six-pack, do you just long for the day when you can do up your jeans without performing a gymnastics routine worthy ...

The study assesses Continuous Glucose monitors accuracy in adults with Diabetic Ketoacidosis (DKA) to improve treatment and ...

KOS AI to Host Press Conference on Argus: A Non-Invasive Blood Glucose Monitoring Breakthrough ...

Insulet unveils positive RADIANT trial clinical data for its Omnipod 5 at the 18th international conference on ATTD.

The rising trend of using diabetes medications for weight loss poses significant health risks. Without medical supervision, ...

Care announced publication by The New England Journal of Medicine of results from the company’s pivotal trial of Control-IQ+ ...

"In Type 1 and Type 2 diabetes, RT-CGM lowered HbA1c, improved time spent within the target glucose range (70–180 mg/dL), and reduced episodes of hypoglycemia in T1D and hypergl ...

Health professionals stress that lasting weight loss is not about quick fixes but making sustainable lifestyle choices ...

The popular anti-obesity drug Mounjaro has finally been launched in India. The development comes after Eli Lilly received ...

AFTER months of careful research, Jennifer Dootson started weight loss injections, hoping to end two decades of yo-yo dieting. A year on, her weight has dropped from almost 14st to 10st 7lbs, and ...

Over 1 in 10 adults worldwide have diabetes, increasing the risk of diabetic retinal disease (DRD), a leading cause of ...